Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 81
Selected: 0
NCT IDTitle
NCT05494060XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
NCT07044908TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal Cancer
NCT06076486A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated Pain
NCT06452706The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
NCT06560593A Phase 1 Clinical Trial of NTQ5082 in Healthy Volunteers
NCT06115902A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer
NCT07052097Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis
NCT01833923A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics
NCT05198505Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors
NCT06449859A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects
NCT06672263A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia
NCT06433531A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP)
NCT06948539To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors
NCT06754891Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
NCT06825494Clinical Studies for the Treatment of Advanced Solid Tumors
NCT06438783TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors
NCT05409326A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects
NCT06977750Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Electrolyte Sodium Acetate Injection
NCT07393321A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast Cancer
NCT05192512Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers
NCT07113925A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies
NCT06764303A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
NCT06798207A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced
NCT02136992Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
NCT06977763Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Injection
NCT06512363A Study of Ramelteon in Chinese Patients With Chronic Insomnia
NCT06767800A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma
NCT05032937the Accuracy and Safety of Coronary Artery Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle
NCT05045872Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance Imaging
NCT06700395A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma
NCT06585059Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers
NCT06496490A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality
NCT07179679A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors
NCT06143423A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.
NCT06230588A Clinical Trial of TQH3906 Capsules in Healthy Volunteers
NCT06146751A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging for the Detection of Intracardiac Thrombus
NCT06219096Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection
NCT06188624Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers
NCT07177859A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
NCT07462130An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED)
NCT06929195Clinical Trial to Evaluate the Tolerance of TQB2210 Injection
NCT06542614Treatment of Moderate to Severe Plaque Psoriasis
NCT07043725A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
NCT05450887Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis
NCT07400406A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries
NCT07182552Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants
NCT07003074A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer
NCT06089278A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.
NCT05735496Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers
NCT07156643A Prospective, Single-arm, Multicenter Exploratory Clinical Study of Anlotinib Combined With Bempegaldesleukin and Conventional Chemoradiotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma.